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Surgical treatment versus medical treatment
in hypertrophic obstructive cardiomyopathy
M. E. ROTHLIN, D. GOBET, T. HABERER, H. P. KRAYENBUEHL,
M. TURINA AND A. SENNING
Medical Department and Surgical Department A, University Hospital, Ziirich, Switzerland
Sixty-three patients operated upon for HOCM and 49 patients selected for non-surgical treatment have been
followed-up for 15 years. Pre-operatively, surgical patients had a higher left ventricular outflow tract gradient
at rest and, on the average, more severe symptoms than non-surgical patients. Septal myectomy relieved the
pressure gradient and symptoms more consistently than long-term treatment with f)-blockers or verapamil.
Within an average observation time of 7'A years, there was late deterioration or death in almost half of the
non-surgical patients but in less than one-quarter in the operated patients. The 10 year mortality rate was 80%
in the surgical series and 71 % in the non-surgical series. In operated patients, pre-operative symptomatic
status was significantly related to early and late mortality. In medically treated patients, mortality was
unrelated to symptoms; however, it was significantly lower in patients receiving long term treatment with
P-blockers or verapamil.
In conclusion, a high basal pressure gradient associated to limiting symptoms is a clear-cut indication for
surgery. Other indications are more debatable. In medically treated patients, long-term administration of
fi-blockers or verapamil is beneficial even without symptoms as it appears to improve prognosis.
Introduction
Surgical treatment for hypertrophic obstructive
cardiomyopathy (HOCM) was introduced at a time
when the condition was thought to be nothing more
than a form of aortic stenosis with the obstruction to
the left ventricular ejection located below the aortic
valve(l). Much has been learned about this condition
in the meantime, and it is understood that the
subvalvular obstruction to the left ventricular
ejection is not the primary cause of the disease. There
are patients with hypertrophic cardiomyopathy and
asymmetric septal hypertrophy, presenting with the
same symptoms and risk of sudden death, who do
not have a left ventricular outflow-tract gradient
(LVOTG). It has been established that hindrance to
diastolic filling plays a very important role to the
pathophysiology of HOCM(2) and that elevated
filling pressure of the left ventricle is related to the
severity of symptoms. Undebated findings in HOCM
are, in analogy to the situation in fixed subvalvular,
valvular and supravalvular aortic stenosis, a systolic
pressure difference between the left ventricular cavity
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and the aorta, a systolic murmur and a prolongation
of the left ventricular ejection time. On the other
hand, left ventricular ejection is not impeded during
the first part of systole in HOCM; moreover, the left
ventricle ejects its content to a larger extent than
normally. The true existence of obstruction to the
left ventricular ejection has been challenged
altogether in HOCM(3), based on observations of an
accelerated systolic ejection, with almost no flow at
the time, during later systole, when LVTOG can be
recorded. The latter observations are in contrast to
previous intra-operative findings'4'3' and recent
echocardiographic observations'6'. The evidence in
these studies was in favour of a substantial blood
flow at the time, when the LVOTG exists and, hence,
in favour of true obstruction to the systolic ejection.
Although this matter remains controversial, it cannot
be overlooked that systolic function is considerably
enhanced in patients with HOCM. It is our belief,
that the benefits of surgical treatment and that of
B-receptor blocking agents'7' are mediated by an
effect on the systolic function, which indirectly
influences diastolic function.
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Table 1 Clinical and haemodynamic data of the surgical
and non-surgical series
Number
Male/female
Age (years)
Mean NYHA class
LVOTG (mmHg)
Mean LAP (mmHg)
Surgical
series
64
41/22
33-7
2-5
77
15-4
Non-surgical
series
49
33/16
34-8
1 9
30
12-5
Surgical treatment consistently relieves the
LVOTG and the symptoms of patients with HOCM.
The effect of the myectomy operation on the course
of the disease is less clear.
Medications, such as D-receptor inhibiting agents
and calcium antagonists, influence the patient's
symptoms and the LVOTG as well, but results are
more variable. Yet the indications for medical or
surgical treatment, respectively, are not the same for
all patients with HOCM, the operation being mostly
performed in the patients with a high LVOTG at rest
and with symptoms which are not readily relieved by
drug therapy. This must be kept in mind when the
long-term course of surgically and medically treated
patients are compared, as is done in this report.
Patients and methods
Between 1965 and 1980, 63 patients underwent 64
myectomy operations for HOCM at the Surgical
Department A of the University Hospital Zurich
(UHZ). All survivors have been followed for more
than 1 year after the operation, the average
observation period being 7-6 years. One patient with
two myectomy operations had two postoperative
courses and therefore there are 64 postoperative
courses that form our surgical series.
During a similar observation time, 68 patients with
HOCM were recorded at the Medical Polyclinic of
the UHZ; 19 out of these were soon referred for
surgery. The remaining 49 patients were followed
with medical management for an average of 7-4
years. They constitute the non-surgical series in this
report. Five of the latter patients were later referred
for surgical treatment after several years of medical
management. Thus 35% of all patients with HOCM
recorded at the Medical Polyclinic of UHZ were
eventually operated upon.
The selection criteria for surgical or non-surgical
treatment are partly reflected by the baseline data of
the two series depicted in Table 1. In both series, the
average age was around 34 years, the male sex being
predominant. In the surgical series, however, the
severity of symptoms, the LVOTG and the left
ventricular filling pressure were greater than in the
non-surgical series.
The surgical methods of septal myectomy were
previously described'8'9'. The myectomy was
performed either through an apical ventriculotomy
or through the aortic valve. In some patients a
combined transaortic and transventricular approach
had to be used. For medical treatment propranolol
was administered at an average dose of 175 mg/day
in 15 patients; another 14 patients were treated with
verapamil at an average dose of 360 mg/day.
For statistical analysis of the results, Student's
-4
Table 2 Preoperalive clinical and haemodynamic data of patients with myeciomy operation
for HOCM. For criteria for patient groups A, B and C see test
Number
Male/female
Age at operation
Symptoms
Preoperative duration
Severity class I — II
Severity class III —IV
Mean LAP (mmHg)
LVED (mmHg)
Group A
28
21/27
29-9±16-5
4-4±3-7
28
0
13-O±4-3
18-8±7-9
Group B
31
18/13
36-7±10-6
9-O±7-8
0
31
16-5±4-I
21-9±71
Group C
5
2/3
29-4±14-6
7-2±3-3
1
4
19-4±8-5
25-2±3-4
-1 m-2CI (I min - ' m
LV gradient (mmHg)
3-3±O-7
100-0±45-3
2-9±0-7
72-O±37-5
2-3±l-5
41-0±39-4
•/MJ-025; **P<0-0\.
Surgical treatment vs. medical treatment in HOCM 217
Mest, the paired Mest and the chi-square test were
used where appropriate. Survival curves were cal-
culated according to Anderson'10'.
Results of surgical treatment as compared to the
* observations in the non-surgical series
According to the criteria for the operative
' indications the surgical series was subdivided into
three patient groups (Table 2). Patients with mild or
transient symptoms formed group A; patients with
-, severe symptoms limiting their daily activity or
occurring at rest formed group B. Group C
comprised patients requiring mitral valve
replacement or reconstruction for predominant
mitral incompetence and one girl with a large left
ventricular aneurysm, which was resected at the same
time.
f~ The average age of patients in group A was lower
and the average duration of pre-operative symptoms
shorter than in group B. Four out of five patients in
group C presented with severe symptoms and with
congestive heart failure. Corresponding to the
clinical observations, left ventricular filling pressure
was lowest and cardiac index highest in group A. The
LVOTG, which greatly influenced the decision for
» surgery in mildly symptomatic patients, was
significantly higher in group A.
Early and late surgical complications are tabulated
v in Table 3. One patient died after early postoperative
tamponade with subsequent multisystem failure.
Four patients required implantation of a pacemaker
because of AV block early after surgery and another
three because of late occurrence of AV dissocation.
Mild aortic incompetence was observed in eight
patients postoperatively, in another one it was more
•• severe and required valve reconstruction. Mitral
incompetence, severe residual left ventricular
outflow obstruction and ventricular septal defect
Table 3 Surgical mortality and complications in 64
myectomy operations for HOCM
Operative death 1
AV block requiring pacemaker:
early 4 and late 3 7
Aortic incompetence
Mild 8
Requiring valve replacement 1
Mitral incompetence requiring valve replacement 1
Residual obstruction requiring reoperation 1
Ventricular septal defect 1
made re-operation necessary in another three
patients.
The pre- and postoperative catheter studies (Fig. 1)
showed the elimination or a considerable reduction
of the LVOTG in all patients with one exception.
Left ventricular filling pressure at rest assessed by left
atrial mean pressure or pulmonary capillary mean
pressure was significantly reduced postoperatively;
LVEDP also was lower after surgery. There was no
significant difference of cardiac index between the
pre- and postoperative studies.
The effect of the operation on the individual
symptoms of HOCM is depicted in Figure 2. All
symptoms were markedly reduced after surgery. The
majority of the group A patients were asymptomatic
for 5 years postoperatively (Fig. 3(a)). Ten years after
surgery, one-third of the patients were again mildly
symptomatic and during the later course recurrence
of symptoms appeared more frequent. The sympto-
matic course in patients of groups B and C shows
excellent initial improvement, with the majority of
patients remaining not more than mildy symptomatic
by the fifth postoperative year (Fig. 3(b) and (c)).
During the later follow-up, however, a slow
symptomatic deterioration is observed.
Fifteen patients of the non-surgical series received
propranolol and 14 received verapamil on a long-
term basis. Twenty non-surgical patients did not
adhere to any medication. Detailed analysis of the
course of symptoms in these patients will be reported
elsewhere0". In Table 4 the initial functional class in
patients of the non-surgical series is compared with
that of the preoperative patients in the surgical
cohort, and it is evident that the latter patients had
considerably more symptoms. After a mean interval
of about 7'/2 years, however, the severity of
symptoms was about the same in both series. The
observed changes in symptoms during the 714 year
course revealed deterioration or death in almost half
of the non-surgical cases, while this occurred in less
than one-quarter of the surgical series. It must be
stressed, however, that 20 out of the 45 non-surgical
patients did not adhere to regular medication.
Analysis of survival in the surgical and non-
surgical series is depicted in Figure 4. Ten year
survival was 80% in the surgical series and 71% in the
non-surgical series', the observed difference did not
reach statistical significance.
Survival curves of the surgical groups A and B
revealed a significant difference with a 100% survival
at 10 years for group A and a 62±12% survival for
group B. Thus, after the myectomy operation,
prognosis was dependent on the severity of pre-
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Group C
n- 3
Preop. Pottop. Prtop. Pottop. Prtop. Pottop.
Figure 1 Effect of myectomy operation on LVOTG (APLV-Ao), left
ventricular end-diastolic pressure (LVEDP) and left atrial pressure or
pulmonary capillary pressure (LAP) in group A, B and C patients with
HOCM. -.group mean value; A, P<0-05; * , P<0-01; A, P<0-0005.
1
Dyjpnoeo Angino Pre-syncope
(n=22)
Syncope Palpitation
I ) ( ) ^ ^^^ I
2 Effect of myectomy operation on the individual symptoms of patients with
HOCM. White area indicates symptom disappeared; stippled area indicates symptom
improved; black area indicates symptom unchanged.
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Figure 3 Symptomatic course after septal
myectomy operation in patients with HOCM in (a)
group A, (b) group B and (c) group C.
operative symptoms, while in the non-surgical series
severity of symptoms was not significantly different
in survivors (average of NYHA class 1 • 8) compared
to deceased patients (average of NYHA class 2-1).
In the non-surgical series there was a significant
difference of survival dependent on the presence of
long-term medication. Ten year survival of patients
receiving propranolol or verapamil was 78% as
compared to 49% in patients who were not taking a
regular drug treatment.
The causes of death in the surgical and non-
surgical series is listed in Table 5. Sudden unexpected
death occurred in only three of the 11 deceased
patients in the surgical series but it occurred in 10 of
the 14 in the non-surgical group.
Holter monitoring in 30 patients of the UHZ
surgical series performed in the late follow-up at an
average interval of 6 'A years after operation revealed
multiform ventricular extrasystoles, bigeminy,
couplets or ventricular tachycardia in 12 patients
(Table 6). It may be seen that patients of group A
had the highest incidence of complicated ventricular
arrhythmia. None of the patients with the more
severe degree of ventricular arrhythmia has died
during a subsequent interval of three years, although
no antiarrhythmic medication was routinely
administered.
Discussion
The postoperative follow-up of patients with
HOCM subjected to septal myectomy is discussed
and compared to the course of HOCM in patients
selected for conservative management at an
institution which refers 35% of its patients with this
disease to surgery. This proportion of operative to
non-operative treatment is very similar to that
reported from the Mayo Clinic'12'. The principal
indications for conservative treatment were no or
mild symptoms only after medical treatment and
absence of a considerable LVOTG at rest. By
contrast, a large LVOTG and severe symptoms were
the most important factors in favour of surgery.
These criteria for the selection of patients for the two
forms of management are well reflected by the
baseline data of the surgical and non-surgical series
presented. Therefore, it has to be stressed again, that
in this report two types of treatment are discussed in
two selected groups of patients with HOCM. More-
over, it must be kept in mind that only 29 of the 49
patients in the non-surgical series adhered to long-
term medication.
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Table 4 Long-term course
NYHA class
I
II
III
IV
Dead
Average class
Average interval (years)
of symptoms in HOCM
Non-surgical
(n = 49)
Initial
examination
9
37
3
0
1-88
group
Last
examination
18
10
7
0
14
1-69
7-4
Surgical group
(n = 64)
Preoperative
examination
9
21
25
9
2-56
Last
postoperative
examination
24
23
6
0
11
1 -66
7-6
"f
100
80
60
40
20
100
"1
(a)
3 4 5 6 7
Time (years)
8 9 10
Figure 4 (a) Survival curves of group A and group
B patients in the surgical series , All patients;
• • , NYHA classes I and II, group A; A A,
NYHA classes III and IV, group B; * , P < 0 0 5
group A to group B. (b) Survival curves of patients in
the non-surgical series with or without long-term
medication , All patients; • • , patients
with medication; O O . patients without
medication; * , P<0-05.
The surgical mortality of one death out of 64
myectomy operations compares favourably to that
reported earlier1'2"16'. However, in surgical series
operated more recently a very low mortality has been
reported by others*'7"19'. Surgical complications
observed in this series have previously been discussed
in relation to operative technique'". It was found
that the myectomy operation through an apical
ventriculotomy carries a higher risk of AV block,
while the transaortic approach caused a higher
incidence of aortic valve incompetence. The latter
complication, associated to the surgical technique
preferred by most surgeons at present, was of mild
degree with one exception.
In agreement with previous reports from this'9-20'
and other institutions02"15' 21' 22), the myectomy
operation abolished the LVOTG and reduced left
ventricular filling pressure in most patients.
Symptoms remained improved for 5 years with few
Table 5 Cause of death in patients with HOCM as related
to the type of treatment
Surgical Non-surgical
Sudden unexpected death
Congestive heart failure
Surgical death
Myocardial infarction
Arrhythmia and shock
Traffic accident
3
5
1
1
1
0
10
3
0
0
0
1
-f
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Table 6 Ventricular arrhythmia recorded by 24 h Hotter
monitoring in patients after myectomy operation for
HOCM
Group A Group B Group C
Postoperative interval 6-7 6-2 4
(years) (1-14) (3-15) (1-6)
No VES 0 0 1
Uniform VES
<30 per hour 6 5 0
Uniform VES
>30 per hour 1 4 1
Multiform VES 2 0 0
Bigemini or couplets 2 3 1
VT 3 1 0
VES = ventricular extrasystole; VT = ventricular tachy-
cardia.
exceptions. Regular examinations up to 15 years
postoperatively revealed, however, slow recurrence
of symptoms in a considerable number of patients.
The functional status at the end of the IVi year
observation period was almost identical in surgical
and non-surgical series. Compared to symptoms at
entry into observation, two-thirds of the operated
patients remain considerably improved or symptom-
free after IVi years, while this is the case in only one-
third of the non-surgical series. On the other hand,
less than one-quarter of patients in the surgical group
experienced deterioration or died during the same
observation time; without surgery, however, this was
the case in half of the patients.
The 10 year survival rate in the surgical series was
80% as compared to 71% in the medical group;
however, this difference did not reach statistical
significance. It is of interest to note that all patients
who had transient or mild chronic symptoms pre-
operatively survived 10 years postoperatively, and
only one patient of this group A died - 15 years after
his operation, of slowly progressive myocardial
failure. On the other hand, patients with symptoms
limiting their activity before surgery, who form
group B, had a 10 year survival of 62% only. The
highest late mortality was observed in the patients
with additional mitral valve surgery or left ventri-
cular aneurysmectomy. In non-surgical patients the
mortality was not related to the symptomatic status
at entry into observation. Earlier reports on the
natural course of HOCM, however, revealed a higher
mortality in severely symptomatic patients'23*.
In non-surgical patients the administration of (3-
receptor inhibitors or verapamil apparently improved
survival. This is a most interesting observation, but it
must be kept in mind that this study was not
prospective and therefore the difference in mortality,
which occurred within the first 2 years of observation
only, may be due to factors other than long-term
medication. Confirmation of this beneficial effect of
/3-receptor inhibitors and verapamil must therefore
be awaited.
Unexpected sudden death is the most common
cause of death in HOCM not subjected to septal
myectomy operation" •23'23) and the non-surgical
series presented here confirm this. After surgery,
however, unexpected sudden death is uncommon,
causing only three of 11 fatalities. The results
reported here, and those of previous reports on the
follow-up of operated patients with HOCM, reveal
20 unexpected sudden deaths during a total of 2028
patient-years, i.e. a yearly rateof 1-O%(I2~132I'12). In
the very large experience of the Royal Postgraduate
Medical School on the natural course of
hypertrophic cardiomyopathy, 32 sudden deaths
were reported within 1524 patient-years,
corresponding to a yearly rate of 2-1% ( 1 ) . A relation
between ventricular arrhythmia and sudden death
has been noted in the latter report. In contrast to
this, our limited experience with Holter monitoring
in patients after septal myectomy for HOCM
revealed the highest incidence of complicated
ventricular arrhythmia in patients of group A, in
whom not a single unexpected sudden death
occurred. It is possible that complicated ventricular
arrhythmia does not have the same meaning in
different forms of the disease or after a septal
myectomy operation.
The most common cause of death in the surgical
series is progressive congestive heart failure. This
complication occurred only years after the operation.
Moreover, in several patients with pre-operative
congestive heart failure this complication was
relieved by surgical intervention for a substantial
time period. It therefore seems unlikely that
congestive heart failure occurring late post-
operatively is caused by myocardial injury due to the
septal myectomy operation.
In conclusion, the septal myectomy operation is
clearly indicated in patients presenting with a
LVOTG at rest of 50 mmHg or more if they have
symptoms limiting their normal activity in spite of
adequate medical treatment. There is no conclusive
evidence yet whether myectomy operation is
beneficial for patients with mild symptoms present-
ing with a very high LVOTG, although the post
operative course has been very favourable in this
subset. Repetitive syncope, previous cardiac arrest or
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sudden death in siblings of the patient may be in
favour of surgical treatment.
If predominant mitral valve incompetence is
present, mitral valve replacement seems to be the
operative method of choice because of the high
incidence of recurrence of mitral incompetence
observed after reconstruction. In patients who do not
meet the criteria for surgery, long-term medical
treatment is beneficial even in the absence of
symptoms because it appears to improve the
prognosis.
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Schulte We know, Dr Rothlin, that Professor
Senning preferred to perform a transventricular
approach for resection of the myocardial obstruc-
tion. Could you find any differences according to
your long-term follow-up data in regard to the
transaortic or transventricular approach?
Rothlin This question has been investigated and it
was discussed a year ago. It is true that in the early
series most patients were operated using a trans-
ventricular approach; in the later series, and at
-f
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present, a transaortic approach, which has been
varied a little bit in the last few years, is preferred. If
we look at the results, we may say that the complete
abolition of the left ventricular outflow tract gradient
has been superior in the patients operated using a
transventricular approach or a combined transventri-
cular and transaortic approach. I may say that in the
early operation around 12 to 14 g of myocardium
were removed. If we look, on the other hand, at the
complications, as I have shown, aortic incompetence
was more frequent with transaortic operations and
AV block more frequent with the transventricular
approach. Now, as far as the late results are
concerned, it is very difficult to give you an answer
because we have used only the transventricular
approach in patients with a follow-up of more than 7
years, while in the other patients we do not have such
a long follow-up, with one exception. The late
deterioration occurs only 6 years or later after the
operation. Therefore, we do not know whether
patients operated through the aortic valve will have
more late problems arising in the future.
Murgo I apologize if I do not remember where you
gave the details of the medical treatment group, but
since Dr Frank had shown that the efficacy of
therapy is related to dose and the time of evaluation,
and Dr Goodwin that various combinations are
important if arrhythmia is present or not, perhaps
you can give us some details as to medical treatment.
Rothlin I apologize, 1 probably forgot to give you
these details. They are important, of course. The
medical treatment comprised 14 patients on pro-
pranolol at an average dosage of 175 m g/day. Some
patients had other /3-blockers but in an equivalent
dosage. The verapamil dosage was on average 360
mg/day. It must be said that out of the 49 patients
who primarily had some medical treatment, 20
patients did not adhere for a very long time to one or
other of these medications. So it is certainly difficult
to compare these medications with surgical treat-
ment, because an operation you can perform and
then the patient stays with it. With medications it
depends very much on what your patient does. It is
again another story what he tells you that he did, if
you do not measure serum levels and so on.
Loogen We have discussed operative treatment
versus conservative treatment but we have not
mentioned one therapeutic alternative, which is used
in several places in our country. That is the
implantation of a pacemaker. Have you any ex-
perience with this method and what is your opinion
of this?
Rothlin We have no therapeutic experience of this,
but we tested pacemaker stimulation about 12 to 15
years ago in patients with hypertrophic obstructive
cardiomyopathy. It was first observed by Hassen-
stein that if you place a pacemaker electrode in the
apex of the right ventricle and you pace the patient
from there, the gradient diminishes or disappears.
We have confirmed this, but in placing a catheter in
different positions, mainly in the right ventricular
outflow tract, to our surprise we observed that the
gradient was greatly increased. We could consistently
show that by placing the catheter in the right place, it
was possible by ventricular pacing to increase the
pressure gradient. This may be important if one has
to treat a patient with an intracavitary pacemaker.
Now, I believe, you have also had some experience
with pacing and that in your experience, and also in
one of my colleagues' patients, ventricular
fibrillation developed. Therefore, 1 did not really go
on along this line. If pacing is necessary in HOCM,
one should use a pacemaker with atrial and ventri-
cular stimulation if this is possible.
Goodwin I would like to take this opportunity on
my own behalf and on behalf of all the invited
participants of thanking Professor Loogen and
Professor Kuhn and congratulate them warmly on
one of the best workshops I have ever attended. It
has fulfilled all the best ideals, I think, of a
workshop, which are those of small numbers of
informed people getting together and discussing
freely and asking questions. Unless you ask the right
questions, you never get any answers at all. Everyone
that I have heard has asked very pertinent and
important questions and I think we owe a great debt
to Professor Loogen and Professor Kuhn and also,
incidentally, to Pharma Schwarz, who have done so
much to oil the wheels and make everything as superb
as it has been. Thank you very much!

